The Asceneuron team will attend AD/PD 2023, the International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. from March 28th to April 1st, in Gothenburg, Sweden.
Asceneuron will participate in the 22nd Annual Biotech in Europe Forum for global partnering and investment (BEF), being held on September 21st-22nd, 2022 in Basel.
Asceneuron will present at the ASBMB O-GlcNAc regulation of cellular physiology and pathophysiology conference on July 7–10, 2022 at the University of Georgia, Athens, GA, USA.